Novo Nordisk Already Plans A 'Next Generation' Oral Semaglutide - CEO

 
• By Sten Stovall
  
Anatomy
Oral Semaglutide Will Be Aimed At Diabetes, Obesity And Fatty Liver • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business